F&P accuses ResMed of stealing ideas, its rival does the same – and tries to stop export and sale of F&P's products.
Calida Smylie Thu, 18 Aug 2016
Two days after Fisher & Paykel Healthcare [NZX:FPH] filed patent infringement proceedings against New York stock exchange-listed ResMed [NYSE:RMD], the rival has turned around and accused F&P of the same thing.
On Tuesday, F&P filed proceedings in the US District Court for the Central District of